1,2-dimethylhydrazine multiple interactions ISO RGD:1551416 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of OPA1 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1551416 6480464 1, 2-Dimethylhydrazine results in decreased expression of OPA1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1551416 6480464 Ethinyl Estradiol affects the expression of OPA1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1551416 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OPA1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1551416 6480464 Ethinyl Estradiol results in increased expression of OPA1 mRNA CTD PMID:17942748 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1551416 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1551416 6480464 Tetrachlorodibenzodioxin results in increased expression of OPA1 mRNA CTD PMID:15328365 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551416 6480464 Tetrachlorodibenzodioxin affects the expression of OPA1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551416 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OPA1 mRNA CTD PMID:17942748 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of OPA1 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1551416 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of OPA1 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1551416 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of OPA1 mRNA CTD PMID:29288687 4,4'-diaminodiphenylmethane increases expression ISO RGD:1551416 6480464 4, 4'-diaminodiphenylmethane results in increased expression of OPA1 mRNA CTD PMID:18648102 4-DAMP(1+) decreases expression EXP 6480464 4-diphenylacetoxy-1, 1-dimethylpiperidinium results in decreased expression of OPA1 protein CTD PMID:27491814 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:1551416 6480464 6-chloro-2 more ... CTD PMID:34738708 acetaldehyde multiple interactions ISO RGD:1344166 6480464 Silybin inhibits the reaction [Acetaldehyde results in decreased expression of OPA1 protein] CTD PMID:35158046 acetaldehyde decreases expression ISO RGD:1344166 6480464 Acetaldehyde results in decreased expression of OPA1 protein CTD PMID:35158046 aconitine decreases expression ISO RGD:1344166 6480464 Aconitine results in decreased expression of OPA1 protein CTD PMID:33945864 acrolein multiple interactions ISO RGD:1344166 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of OPA1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of OPA1 mRNA CTD PMID:32699268 acrolein increases expression EXP 6480464 Acrolein results in increased expression of OPA1 mRNA CTD PMID:35150775 actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [15-deoxyprostaglandin J2 results in increased expression of OPA1 protein alternative form] CTD PMID:20678484 aflatoxin B1 increases methylation ISO RGD:1344166 6480464 Aflatoxin B1 results in increased methylation of OPA1 gene CTD PMID:27153756 AICA ribonucleotide multiple interactions EXP 6480464 AICA ribonucleotide inhibits the reaction [Acetaminophen results in decreased expression of OPA1 protein], AICA ribonucleotide inhibits the reaction [Diclofenac results in decreased expression of OPA1 protein] CTD PMID:27792760 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of OPA1 protein CTD PMID:27684054 , PMID:30144576 aldehydo-D-glucose increases expression ISO RGD:1344166 6480464 Glucose results in increased expression of OPA1 mRNA CTD PMID:33962019 aldehydo-D-glucose multiple interactions ISO RGD:1344166 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA] CTD PMID:33962019 aldehydo-D-glucose multiple interactions EXP 6480464 cinnamic acid inhibits the reaction [Glucose results in decreased expression of OPA1 protein], Metformin inhibits the reaction [Glucose results in decreased expression of OPA1 protein] CTD PMID:30144576 alpha-pinene multiple interactions ISO RGD:1344166 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of OPA1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of OPA1 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of OPA1 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:1344166 6480464 Antirheumatic Agents results in increased expression of OPA1 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1344166 6480464 aristolochic acid I results in decreased expression of OPA1 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1344166 6480464 arsenite inhibits the reaction [G3BP1 protein binds to OPA1 mRNA] CTD PMID:32406909 arsenite(3-) increases expression ISO RGD:1551416 6480464 arsenite results in increased expression of OPA1 mRNA CTD PMID:24960579 arsenous acid multiple interactions ISO RGD:1551416 6480464 salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of OPA1 protein] CTD PMID:29867492 arsenous acid multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of OPA1 protein] CTD PMID:29867492 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of OPA1 protein CTD PMID:29867492 arsenous acid increases expression ISO RGD:1551416 6480464 Arsenic Trioxide results in increased expression of OPA1 protein CTD PMID:29867492 benzo[a]pyrene decreases expression ISO RGD:1551416 6480464 Benzo(a)pyrene results in decreased expression of OPA1 mRNA CTD PMID:20504355 benzo[a]pyrene affects methylation ISO RGD:1344166 6480464 Benzo(a)pyrene affects the methylation of OPA1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1551416 6480464 Benzo(a)pyrene results in increased expression of OPA1 mRNA CTD PMID:21715664 , PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1344166 6480464 7 more ... CTD PMID:26238291 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of OPA1 mRNA CTD PMID:30816183 more ... bisphenol A multiple interactions ISO RGD:1344166 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of OPA1 gene CTD PMID:31601247 bisphenol A increases methylation ISO RGD:1344166 6480464 bisphenol A results in increased methylation of OPA1 gene CTD PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of OPA1 gene CTD PMID:28505145 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of OPA1 protein CTD PMID:28903499 butanal decreases expression ISO RGD:1344166 6480464 butyraldehyde results in decreased expression of OPA1 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:1344166 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OPA1 mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO RGD:1344166 6480464 Cadmium Chloride results in increased expression of OPA1 mRNA CTD PMID:26472689 cadmium dichloride multiple interactions ISO RGD:1344166 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OPA1 mRNA CTD PMID:35301059 cannabidiol increases expression ISO RGD:1344166 6480464 Cannabidiol results in increased expression of OPA1 mRNA CTD PMID:27714895 carnosic acid increases expression ISO RGD:1344166 6480464 salvin results in increased expression of OPA1 protein CTD PMID:31705926 carnosic acid multiple interactions ISO RGD:1344166 6480464 OPA1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of CASP3 protein]] more ... CTD PMID:31705926 CCCP decreases expression ISO RGD:1344166 6480464 Carbonyl Cyanide m-Chlorophenyl Hydrazone results in decreased expression of OPA1 protein alternative form CTD PMID:28940366 CGP 52608 multiple interactions ISO RGD:1344166 6480464 CGP 52608 promotes the reaction [RORA protein binds to OPA1 gene] CTD PMID:28238834 chlorpyrifos decreases expression ISO RGD:1551416 6480464 Chlorpyrifos results in decreased expression of OPA1 mRNA CTD PMID:29156651 cisplatin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Cisplatin results in decreased expression of OPA1 protein] CTD PMID:28698153 cisplatin multiple interactions ISO RGD:1551416 6480464 [N-(oxo-5 more ... CTD PMID:31133874 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of OPA1 protein CTD PMID:28698153 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Cisplatin results in decreased expression of OPA1 protein] CTD PMID:28698153 cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [15-deoxyprostaglandin J2 results in increased expression of OPA1 protein alternative form] CTD PMID:20678484 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of OPA1 protein CTD PMID:27684054 , PMID:30144576 D-glucose increases expression ISO RGD:1344166 6480464 Glucose results in increased expression of OPA1 mRNA CTD PMID:33962019 D-glucose multiple interactions ISO RGD:1344166 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA] CTD PMID:33962019 D-glucose multiple interactions EXP 6480464 cinnamic acid inhibits the reaction [Glucose results in decreased expression of OPA1 protein], Metformin inhibits the reaction [Glucose results in decreased expression of OPA1 protein] CTD PMID:30144576 desferrioxamine B multiple interactions ISO RGD:1344166 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA] CTD PMID:33962019 desferrioxamine B increases expression ISO RGD:1344166 6480464 Deferoxamine results in increased expression of OPA1 mRNA CTD PMID:33962019 dexamethasone multiple interactions ISO RGD:1551416 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of OPA1 mRNA CTD PMID:29288687 diarsenic trioxide increases expression ISO RGD:1551416 6480464 Arsenic Trioxide results in increased expression of OPA1 protein CTD PMID:29867492 diarsenic trioxide multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of OPA1 protein] CTD PMID:29867492 diarsenic trioxide multiple interactions ISO RGD:1551416 6480464 salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of OPA1 protein] CTD PMID:29867492 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of OPA1 protein CTD PMID:29867492 dibutyl phthalate decreases expression ISO RGD:1551416 6480464 Dibutyl Phthalate results in decreased expression of OPA1 mRNA CTD PMID:21266533 diclofenac decreases expression ISO RGD:1551416 6480464 Diclofenac results in decreased expression of OPA1 mRNA CTD PMID:26934552 diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of OPA1 protein CTD PMID:27792760 diclofenac multiple interactions EXP 6480464 AICA ribonucleotide inhibits the reaction [Diclofenac results in decreased expression of OPA1 protein] CTD PMID:27792760 Didecyldimethylammonium increases expression ISO RGD:1344166 6480464 didecyldimethylammonium results in increased expression of OPA1 protein CTD PMID:32763356 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of OPA1 mRNA CTD PMID:22546817 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of OPA1 protein CTD PMID:27684054 dioxygen multiple interactions EXP 6480464 sevoflurane inhibits the reaction [Oxygen deficiency results in decreased expression of OPA1 protein] CTD PMID:27684054 dorsomorphin decreases expression EXP 6480464 dorsomorphin results in decreased expression of OPA1 protein CTD PMID:27491814 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of OPA1 protein CTD PMID:26678157 , PMID:35093381 doxorubicin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Doxorubicin results in decreased expression of OPA1 protein] more ... CTD PMID:35093381 efavirenz increases expression ISO RGD:1344166 6480464 efavirenz results in increased expression of OPA1 mRNA CTD PMID:28940366 elemental selenium decreases expression ISO RGD:1344166 6480464 Selenium results in decreased expression of OPA1 mRNA CTD PMID:19244175 ethanol affects splicing ISO RGD:1551416 6480464 Ethanol affects the splicing of OPA1 mRNA CTD PMID:30319688 ethanol decreases expression ISO RGD:1344166 6480464 Ethanol results in decreased expression of OPA1 protein CTD PMID:35158046 ethanol multiple interactions ISO RGD:1344166 6480464 Silybin inhibits the reaction [Ethanol results in decreased expression of OPA1 protein] CTD PMID:35158046 fenbendazole increases expression ISO RGD:1344166 6480464 Fenbendazole results in increased expression of OPA1 mRNA CTD PMID:35569513 fenofibrate multiple interactions ISO RGD:1344166 6480464 Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of OPA1 protein] CTD PMID:32730863 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of OPA1 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:1551416 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of OPA1 mRNA] CTD PMID:22206623 formaldehyde decreases expression ISO RGD:1344166 6480464 Formaldehyde results in decreased expression of OPA1 mRNA CTD PMID:23649840 fructose multiple interactions ISO RGD:1344166 6480464 [Fructose co-treated with Palmitic Acid] results in decreased expression of OPA1 protein, Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of OPA1 protein] CTD PMID:32730863 fulvestrant multiple interactions ISO RGD:1344166 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of OPA1 gene CTD PMID:31601247 glucose decreases expression EXP 6480464 Glucose results in decreased expression of OPA1 protein CTD PMID:27684054 , PMID:30144576 glucose increases expression ISO RGD:1344166 6480464 Glucose results in increased expression of OPA1 mRNA CTD PMID:33962019 glucose multiple interactions ISO RGD:1344166 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA] CTD PMID:33962019 glucose multiple interactions EXP 6480464 cinnamic acid inhibits the reaction [Glucose results in decreased expression of OPA1 protein], Metformin inhibits the reaction [Glucose results in decreased expression of OPA1 protein] CTD PMID:30144576 hexadecanoic acid multiple interactions ISO RGD:1344166 6480464 [Fructose co-treated with Palmitic Acid] results in decreased expression of OPA1 protein, Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of OPA1 protein] CTD PMID:32730863 Honokiol multiple interactions EXP 6480464 honokiol inhibits the reaction [amyloid beta-protein (1-42) results in decreased expression of OPA1 protein], SIRT3 protein affects the reaction [honokiol inhibits the reaction [amyloid beta-protein (1-42) results in decreased expression of OPA1 protein]] CTD PMID:34752757 hydralazine multiple interactions ISO RGD:1344166 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of OPA1 mRNA CTD PMID:17183730 hydrogen peroxide decreases expression ISO RGD:1344166 6480464 Hydrogen Peroxide results in decreased expression of OPA1 mRNA CTD PMID:30316844 hydrogen peroxide multiple interactions ISO RGD:1344166 6480464 BMAL1 protein affects the reaction [Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of OPA1 mRNA]], Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of OPA1 mRNA] CTD PMID:30316844 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of OPA1 protein CTD PMID:27491814 ivermectin decreases expression ISO RGD:1344166 6480464 Ivermectin results in decreased expression of OPA1 protein CTD PMID:32959892 lamivudine multiple interactions ISO RGD:1551416 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of OPA1 mRNA CTD PMID:18313992 lenvatinib increases expression EXP 6480464 lenvatinib results in increased expression of OPA1 mRNA CTD PMID:34019861 Licarin A multiple interactions ISO RGD:1551416 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of OPA1 mRNA CTD PMID:29288687 manganese(II) chloride decreases expression ISO RGD:1551416 6480464 manganese chloride results in decreased expression of OPA1 protein CTD PMID:34738708 manganese(II) chloride multiple interactions ISO RGD:1551416 6480464 6-chloro-2 more ... CTD PMID:34738708 melatonin multiple interactions ISO RGD:1344166 6480464 Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of OPA1 mRNA] CTD PMID:33962019 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Doxorubicin results in decreased expression of OPA1 protein] more ... CTD PMID:35093381 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Glucose results in decreased expression of OPA1 protein] CTD PMID:30144576 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of OPA1 mRNA CTD PMID:30467583 methidathion decreases expression ISO RGD:1551416 6480464 methidathion results in decreased expression of OPA1 mRNA CTD PMID:34813904 methyl methanesulfonate decreases expression ISO RGD:1344166 6480464 Methyl Methanesulfonate results in decreased expression of OPA1 mRNA CTD PMID:23649840 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [15-deoxyprostaglandin J2 results in increased expression of OPA1 protein alternative form], Acetylcysteine inhibits the reaction [15-deoxyprostaglandin J2 results in increased ubiquitination of OPA1 protein] CTD PMID:20678484 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of OPA1 protein alternative form CTD PMID:20678484 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of OPA1 mRNA CTD PMID:20360939 nitrogen dioxide multiple interactions ISO RGD:1551416 6480464 [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of OPA1 protein CTD PMID:27521637 okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of OPA1 protein CTD PMID:26732598 oxidopamine multiple interactions EXP 6480464 isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA] more ... CTD PMID:25129099 oxidopamine multiple interactions ISO RGD:1344166 6480464 OPA1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of CASP3 protein]] more ... CTD PMID:31705926 oxidopamine decreases expression ISO RGD:1344166 6480464 Oxidopamine results in decreased expression of OPA1 protein CTD PMID:31705926 oxidopamine decreases expression EXP 6480464 Oxidopamine results in decreased expression of OPA1 mRNA CTD PMID:25129099 ozone multiple interactions ISO RGD:1344166 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of OPA1 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1551416 6480464 Acetaminophen affects the expression of OPA1 mRNA CTD PMID:17562736 paracetamol multiple interactions EXP 6480464 AICA ribonucleotide inhibits the reaction [Acetaminophen results in decreased expression of OPA1 protein] CTD PMID:27792760 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of OPA1 protein CTD PMID:27792760 paracetamol decreases expression ISO RGD:1344166 6480464 Acetaminophen results in decreased expression of OPA1 mRNA CTD PMID:21420995 more ... phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of OPA1 mRNA CTD PMID:20360939 piroxicam decreases expression ISO RGD:1344166 6480464 Piroxicam results in decreased expression of OPA1 mRNA CTD PMID:21858171 quercetin 3-O-beta-D-glucofuranoside multiple interactions EXP 6480464 isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA] CTD PMID:25129099 quercetin 3-O-beta-D-glucopyranoside multiple interactions EXP 6480464 isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA] CTD PMID:25129099 regorafenib increases expression EXP 6480464 regorafenib results in increased expression of OPA1 mRNA CTD PMID:33166663 resveratrol decreases expression ISO RGD:1344166 6480464 resveratrol results in decreased expression of OPA1 protein CTD PMID:18089832 resveratrol multiple interactions ISO RGD:1551416 6480464 6-chloro-2 more ... CTD PMID:34738708 resveratrol multiple interactions ISO RGD:1344166 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of OPA1 mRNA CTD PMID:23557933 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Rotenone results in decreased expression of OPA1 mRNA] more ... CTD PMID:26770656 rimonabant multiple interactions ISO RGD:1551416 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of OPA1 mRNA] CTD PMID:19030233 rotenone increases expression ISO RGD:1344166 6480464 Rotenone results in increased expression of OPA1 protein CTD PMID:21223980 rotenone multiple interactions EXP 6480464 resveratrol inhibits the reaction [Rotenone results in decreased expression of OPA1 mRNA] more ... CTD PMID:26770656 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of OPA1 mRNA, Rotenone results in decreased expression of OPA1 protein CTD PMID:26770656 rotenone increases expression EXP 6480464 Rotenone results in increased expression of OPA1 mRNA, Rotenone results in increased expression of OPA1 protein CTD PMID:19013527 , PMID:35544339 rutin multiple interactions EXP 6480464 Rutin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA] CTD PMID:25129099 Salvianolic acid A multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of OPA1 protein] CTD PMID:29867492 Salvianolic acid A multiple interactions ISO RGD:1551416 6480464 salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of OPA1 protein] CTD PMID:29867492 selenium atom decreases expression ISO RGD:1344166 6480464 Selenium results in decreased expression of OPA1 mRNA CTD PMID:19244175 sevoflurane multiple interactions EXP 6480464 sevoflurane inhibits the reaction [Oxygen deficiency results in decreased expression of OPA1 protein] CTD PMID:27684054 silibinin multiple interactions ISO RGD:1344166 6480464 Silybin inhibits the reaction [Acetaldehyde results in decreased expression of OPA1 protein], Silybin inhibits the reaction [Ethanol results in decreased expression of OPA1 protein] CTD PMID:35158046 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of OPA1 protein CTD PMID:29459688 sodium fluoride decreases expression ISO RGD:1551416 6480464 Sodium Fluoride results in decreased expression of OPA1 protein CTD PMID:28918527 sulfur dioxide multiple interactions ISO RGD:1551416 6480464 [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in decreased expression of OPA1 protein CTD PMID:27521637 tamoxifen affects expression ISO RGD:1551416 6480464 Tamoxifen affects the expression of OPA1 mRNA CTD PMID:17555576 testosterone decreases expression ISO RGD:1344166 6480464 Testosterone results in decreased expression of OPA1 mRNA CTD PMID:33359661 thapsigargin increases expression ISO RGD:1344166 6480464 Thapsigargin results in increased expression of OPA1 mRNA CTD PMID:28940366 trans-cinnamic acid multiple interactions EXP 6480464 cinnamic acid inhibits the reaction [Glucose results in decreased expression of OPA1 protein] CTD PMID:30144576 tungsten decreases expression ISO RGD:1551416 6480464 Tungsten results in decreased expression of OPA1 mRNA CTD PMID:30912803 valproic acid multiple interactions ISO RGD:1344166 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of OPA1 mRNA CTD PMID:17183730 valproic acid affects expression ISO RGD:1344166 6480464 Valproic Acid affects the expression of OPA1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1344166 6480464 Valproic Acid results in decreased expression of OPA1 mRNA CTD PMID:23179753 verteporfin multiple interactions EXP 6480464 Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of OPA1 protein]] CTD PMID:35093381 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of OPA1 mRNA CTD PMID:19015723 zidovudine multiple interactions ISO RGD:1551416 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of OPA1 mRNA CTD PMID:18313992 zidovudine multiple interactions ISO RGD:1344166 6480464 [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of OPA1 mRNA, [DTYMK protein affects the susceptibility to Zidovudine] which affects the expression of OPA1 protein CTD PMID:28683400